This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / India's Pharma Exports Grow
Business export growth

India's Pharma Exports Grow

Analysis based on 11 articles · First reported Apr 04, 2026 · Last updated Apr 04, 2026

Sentiment
60
Attention
4
Articles
11
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The positive growth in India's pharmaceutical exports, despite global challenges, signals a robust sector with significant future potential, positively impacting investor confidence in India's economy. The weakening India — Indian rupee is also expected to boost export figures in local currency terms, further supporting the sector.

Pharmaceuticals
Event Summary

India's pharmaceutical exports reached over USD 28 billion by February of the current financial year (FY26), marking a 5.6% growth compared to the previous year. The India — Pharmaceuticals Export Promotion Council of India (Pharmexcil) reported that exports for FY2024-25 were USD 30.47 billion, a 9.4% year-on-year increase. K. Raja Bhanu, Director General of Pharmexcil, projects the sector to grow from its current USD 60 billion to USD 130 billion by 2030, with exports aiming for USD 65 billion. The United States accounts for 34% of India's pharmaceutical exports, followed by Europe at 19%. Rajesh Agrawal, Secretary in the Department of Commerce, noted that exports would show growth in rupee terms due to the weakening India — Indian rupee. Namit Joshi, Chairman of Pharmexcil, expects FY26 figures to be similar to FY25, partly due to higher procurement by the United States in 2025.

Entities Involved
govactor
India — Pharmaceuticals Export Promotion Council of India
The India — Pharmaceuticals Export Promotion Council of India (Pharmexcil) is the primary source of information and projections regarding India's pharmaceutical exports, setting targets and outlining strategies for growth.
Importance 90.0 Sentiment 60.0
per
K. Raja Bhanu
K. Raja Bhanu, Director General of the India — Pharmaceuticals Export Promotion Council of India (Pharmexcil), provided key statistics and future projections for India's pharmaceutical export sector.
Importance 80.0 Sentiment 60.0
per
Namit Joshi
Namit Joshi, Chairman of the India — Pharmaceuticals Export Promotion Council of India (Pharmexcil), commented on the expected performance of India's pharmaceutical exports for the current financial year.
Importance 60.0 Sentiment 50.0
per
Rajesh Agrawal
Rajesh Agrawal, Secretary in the Department of Commerce, highlighted that India's exports would show growth in rupee terms due to the weakening India — Indian rupee.
Importance 50.0 Sentiment 50.0
curr
India — Indian rupee
Importance 0.0 Sentiment 0.0
cnt
United States
Importance 0.0 Sentiment 0.0
loc
Europe
Importance 0.0 Sentiment 0.0
cnt
India
Importance 0.0 Sentiment 0.0
Relationships
Rajesh Agrawal related ↔ United States
Rajesh Agrawal related ↔ India
United States strategic partner ↔ India The United States considers India a key geopolitical partner and major trade destination in Asia, investing heavily in i
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.